Mergers & Acquisitions
By The Online Investor Staff, updated Sun., Jan. 29, 5:53 PM
| This Slide: #92 of 100 |
Slide #92. Psyence Group Inc. — Newcourt Acquisition Corp
Acquirer:
Psyence Group Inc. (PSYGF)
Acquiree:
Newcourt Acquisition Corp (NASDAQ:NCAC)
Details:
Psyence Group Inc. (CSE:PSYG | OTCQB: PSYGF), a life science biotechnology company pioneering the use of natural psilocybin in mental health and well-being ("Psyence"), and Newcourt Acquisition Corp (NASDAQ:NCAC), a special purpose acquisition company ("SPAC") formed for the purpose of acquiring or merging with one or more businesses ("Newcourt" or the "Company"), today announced that Newcourt has entered into a definitive business combination agreement (the "Business Combination Agreement") on January 9, 2023 with Psyence Biomed Corp ("Psyence Biomed"), a wholly owned subsidiary of Psyence, to create a public company (the "Combined Company") leveraging natural psilocybin in the treatment of palliative care (the "Business Combination"). Psyence Biomed is Psyence's clinical trial division.
Open the NCAC Page at The Online Investor »
|
||||||
Open the NCAC Page at The Online Investor (in a new window) »
 Free NCAC Email Alerts:
Get SEC Filing Alerts Get Dividend Alerts 
|
